On March 8, Omrix Biopharmaceuticals
- The top line was up more than 100%, thanks to an increase in unit sales of Evicel and Quixil.
- A stock offering helped raise cash and cash equivalents by $80.8 million. This led to a 44% increase in diluted share count.
- The FDA accepted the company's Investigational New Drug application for Adhexil, an anti-adhesion product candidate, allowing the initiation of clinical trials.
- For year 2007, product sales are expected to be in range of $50 million to $55 million. This is slightly lower than 2006 product sales of $57 million.
(Figures in thousands, except per-share data)
Income Statement Highlights
Q4 2006 |
Q4 2005 |
Change |
|
---|---|---|---|
Sales |
$18,044 |
$8,328 |
116.7% |
Net Profit |
$6,390 |
$93 |
6771.0% |
EPS |
$0.41 |
$0.01 |
4000.0% |
Diluted Shares |
15,601.2 |
10,871.3 |
43.5% |
Get back to basics with a look at the income statement.
Margin Checkup
Q4 2006 |
Q4 2005 |
Change* |
|
---|---|---|---|
Gross Margin |
50.5% |
30.6% |
19.8 |
Operating Margin |
30.6% |
7.6% |
23.0 |
Net Margin |
35.4% |
1.1% |
34.3 |
Margins are the earnings engine.
Balance Sheet Highlights
Assets |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$80,822 |
$6,494 |
1144.6% |
Accounts Rec. |
$9,748 |
$5,344 |
82.4% |
Inventory |
$17,419 |
$6,793 |
156.4% |
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Accounts Payable* |
$7,498 |
$5,995 |
25.1% |
Long-Term Debt |
$394 |
$6,026 |
(93.5%) |
The balance sheet reflects the company's health.
Cash Flow Highlights
Cash flow data is not available.
Free cash flow is a Fool's best friend.
Related Foolishness:
Omrix Biopharmaceuticals is a Rule Breakers recommendation. A free 30-day trial to the newsletter will let you find out why.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.